New Strategies for Macrophage Re-Education in Cancer: An Update
Author:
Open Access
- 18 March 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (6) , 3414
Abstract
The association between cancer and inflammation is well established. Chronic inflammation represents a fundamental step in the development and progression of some types of cancer. Tumors are composed of a heterogeneous population of infiltrating cells including macrophages, fibroblasts, lymphocytes, granulocytes, and mast cells, which respond to signals from the microenvironment and, in turn, produce cytokines, chemokines, transcription factors, receptors, and miRNAs. Recent data demonstrate that, in addition to classical (M1) and alternative (M2) macrophage subtypes, there are many intermediate subtypes that potentially play different roles in response to environmental stimuli. Tumors are infiltrated by macrophages called TAMs that mainly display an M2-like phenotype and tumor growth-permissive activities. There is a bidirectional interaction between tumor cells and tumor-infiltrating cells that determines macrophage polarization and ultimately tumor progression or regression. These complex interactions are still unclear but understanding them is fundamental for the development of new therapeutic strategies. Re-educating tumor-permissive macrophages into anti-tumor macrophages is a new focus of research. This review aims to analyze the most recent articles investigating the interplay between tumors, tumor-infiltrating cells, and TAMs, and the strategies for re-educating tumor-permissive macrophages.Keywords
This publication has 130 references indexed in Scilit:
- Hypoxia‐induced miR‐210‐3p expression in lung adenocarcinoma potentiates tumor development by regulating CCL2 mediated monocyte infiltrationMolecular Oncology, 2024
- HMGB1 in exosomes derived from gastric cancer cells induces M2‐like macrophage polarization by inhibiting the NF‐κB signaling pathwayCell Biology International, 2023
- SPI1‐mediated CXCL12 expression in bladder cancer affects the recruitment of tumor‐associated macrophagesMolecular Carcinogenesis, 2023
- Interplay between signal transducers and activators of transcription (STAT) proteins and cancer: involvement, therapeutic and prognostic perspectiveClinical and Experimental Medicine, 2023
- Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironmentCancer Immunology, Immunotherapy, 2023
- Collagen VI sustains cell stemness and chemotherapy resistance in glioblastomaCellular and Molecular Life Sciences, 2023
- PD‐L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedsideClinical and Experimental Dental Research, 2022
- Engineering Endogenous Tumor‐Associated Macrophage‐Targeted Biomimetic Nano‐RBC to Reprogram Tumor Immunosuppressive Microenvironment for Enhanced Chemo‐ImmunotherapyAdvanced Materials, 2021
- Systemic Immunotherapy with Micellar Resiquimod–Polymer Conjugates Triggers a Robust Antitumor Response in a Breast Cancer ModelAdvanced Healthcare Materials, 2021
- M2b macrophage polarization and its roles in diseasesJournal of Leukocyte Biology, 2018